Asset Acquisition, Royalty Payment On Net Sales, Percent

No definition available.

Name:	pths_AssetAcquisitionRoyaltyPaymentOnNetSalesPercent
Namespace Prefix:	pths_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479908/805-50-55-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480060/805-50-25-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480027/805-50-30-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480027/805-50-30-2

+ Details

Name:	us-gaap_AssetAcquisitionConsiderationTransferred
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480060/805-50-25-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480027/805-50-30-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480027/805-50-30-2

+ Details

Name:	us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of transaction cost incurred as part of consideration transferred in asset acquisition.

+ References

+ Details

Name:	us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-4

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 15
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480123/805-50-15-3

+ Details

Name:	us-gaap_AssetAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.

+ References

+ Details

Name:	us-gaap_PaymentsToAcquireProductiveAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	pths_AssetAcquisitionConsiderationTypeAxis=pths_AssetAcquisitionContractualAmountMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AssetAcquisitionAxis=pths_XEPITransactionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=pths_BiofronteraInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	pths_AssetAcquisitionContingentConsiderationTypeAxis=pths_ContingentConsiderationAchievementOfCommercialQuantitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	pths_AssetAcquisitionContingentConsiderationTypeAxis=pths_ContingentConsiderationAchievementOfSalesBasedMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=pths_FerrerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	pths_AssetAcquisitionContingentConsiderationTypeAxis=pths_ContingentConsiderationAcceptanceOfInitialAPIPurchaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=pths_VariousMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	pths_AssetAcquisitionConsiderationTypeAxis=pths_AssetAcquisitionAllocatedPurchasePriceMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

GOODWILL AND INTANGIBLE ASSETS - Schedule of Consideration For Asset Acquisition (Details) - XEPI Transaction - USD ($) $ in Thousands		12 Months Ended
	Nov. 06, 2025	Dec. 31, 2025
Contractual Amount
Asset Acquisition [Line Items]
Consideration transferred		$ 12,080
Contractual Amount \| Biofrontera
Asset Acquisition [Line Items]
Upfront Payment - Asset Purchase Agreement		3,000
Contractual Amount \| Biofrontera \| Contingent Consideration - Achievement of Commercial Quantities
Asset Acquisition [Line Items]
Contingent consideration	$ 1,000	1,000
Contractual Amount \| Biofrontera \| Contingent Consideration - Achievement of Sales Based Milestones
Asset Acquisition [Line Items]
Contingent consideration		$ 6,000
Contractual Amount \| Ferrer
Asset Acquisition [Line Items]
Royalty Payments on Net Sales of Xepi		7.00%
Contractual Amount \| Ferrer \| Contingent Consideration - Acceptance of Initial API Purchase
Asset Acquisition [Line Items]
Contingent consideration	$ 1,200	$ 1,200
Contractual Amount \| Various
Asset Acquisition [Line Items]
Xepi Transaction - Transaction Expenses		880
Allocated Purchase Price
Asset Acquisition [Line Items]
Consideration transferred		6,080
Allocated Purchase Price \| Biofrontera
Asset Acquisition [Line Items]
Upfront Payment - Asset Purchase Agreement		3,000
Allocated Purchase Price \| Biofrontera \| Contingent Consideration - Achievement of Commercial Quantities
Asset Acquisition [Line Items]
Contingent consideration		1,000
Allocated Purchase Price \| Biofrontera \| Contingent Consideration - Achievement of Sales Based Milestones
Asset Acquisition [Line Items]
Contingent consideration		$ 0
Allocated Purchase Price \| Ferrer
Asset Acquisition [Line Items]
Royalty Payments on Net Sales of Xepi		0.00%
Allocated Purchase Price \| Ferrer \| Contingent Consideration - Acceptance of Initial API Purchase
Asset Acquisition [Line Items]
Contingent consideration		$ 1,200
Allocated Purchase Price \| Various
Asset Acquisition [Line Items]
Xepi Transaction - Transaction Expenses		$ 880